Atea Pharmaceuticals | DEFA14A:其他
04/26 16:40 (美东)
Atea Pharmaceuticals | DEF 14A:股东委托书决议
04/26 16:26 (美东)
Atea Pharmaceuticals | 10-K:年度报表
02/28 22:56 (美东)
Atea Pharmaceuticals | 8-K:Atea Pharmicals公布2023年第四季度和全年财务业绩并提供业务最新情况
02/28 16:29 (美东)
Atea Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%)等
02/14 20:08 (美东)
Atea Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%)等
02/14 11:37 (美东)
Atea Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(8.4%),Oleg Nodelman(8.4%)等
02/14 09:17 (美东)
Atea Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.51%)
02/13 17:01 (美东)
Atea Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Jean-Pierre Sommadossi(9.6%),JPM Partners LLC(7.1%)
02/13 16:35 (美东)
Atea Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(6.412%),Abigail P. Johnson(6.412%)
02/09 08:39 (美东)
Atea Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Braden M Leonard(6.7%),BML Investment Partners, L.P.(6.5%)
02/07 09:30 (美东)
Atea Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Braden M Leonard(6.7%),BML Investment Partners, L.P.(6.5%)
02/07 09:16 (美东)
Atea Pharmaceuticals | 4:持股变动声明-高管 Corcoran Andrea
02/02 21:37 (美东)
Atea Pharmaceuticals | 4:持股变动声明-高管 Sommadossi Jean-Pierre
02/02 21:32 (美东)
Atea Pharmaceuticals | 4:持股变动声明-高管 Horga Maria Arantxa
02/02 21:32 (美东)
Atea Pharmaceuticals | 4:持股变动声明-高管 Foster Wayne
02/02 21:31 (美东)
Atea Pharmaceuticals | 4:持股变动声明-高管 Vavricka John
02/02 21:27 (美东)
Atea Pharmaceuticals | 4:持股变动声明-高管 Hammond Janet MJ
02/02 21:27 (美东)
Atea Pharmaceuticals | 144:拟议出售证券
02/01 16:17 (美东)
Atea Pharmaceuticals | 144:拟议出售证券
02/01 16:17 (美东)
暂无数据
暂无数据